Lōvu key facts
as of Oct 2026- Developer of an AI-enabled care platform designed to increase awareness by delivering instant analytics and evidence-based insights.
- Lōvu is valued at approximately $31.0M as of Oct 2026 (last reported valuation).
- It has raised $14.9M; the latest was Early Stage VC ($8.0M) in May 2025.
- Notable investors include Alumni Ventures, Matter (Consulting Services (B2B)), Sand Hill Angels, SJF Ventures, Swizzle Ventures — 14 tracked in total.
- Status: Privately Held (backing).
Lōvu's last reported valuation, May 2025. Nothing priced has surfaced since.
- ·The complete investor list: 14 names
- ·Watch Lōvu: the Monday email on marks, rounds and moves
Lōvu funding rounds
No funding rounds for Lōvu are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
Who backs Lōvu
14+Lōvu valuation
Lōvu's last reported valuation was $31 million in May 2025. No priced round, secondary trade or fund mark has surfaced since.
Lōvu investors
14 investors are on record for Lōvu, including Alumni Ventures, Matter (Consulting Services (B2B)), Sand Hill Angels and SJF Ventures. By type, the record holds 6 venture capital firms.
About Lōvu
Developer of an AI-enabled care platform designed to increase awareness by delivering instant analytics and evidence-based insights. The company's platform offers features like observing fetal heart rate and blood pressure, evidence-based recommendations, action-oriented alerts, self-monitoring insights and identifying potentially life-threatening conditions, enabling patients with rapid access, reliable information and evidence-based know-how.
- Sector
- Healthcare
- HQ
- Los Gatos, CA, United States
- Founded
- 2022
- Employees
- 25
- Website
- lovu.health/
- Ownership
- Privately Held (backing)
Is this your company? Sign in with your work email to keep it current, or tell us what's wrong.